ApoB particles entering the arterial wall is only the start; the inflammation that follows is what drives a plaque toward rupture, and part of the statin benefit is plaque stabilisation.
Inflammaging is the same chronic low-grade inflammation machinery seen through the lens of ageing — one NF-kB to IL-6 to CRP pathway, drifting upward with the years.